Gentian Violet Treatment for Hidradenitis Suppurativa

Withdrawn before enrolling · Phase 2

Conditions studied: Hidradenitis Suppurativa

In brief

This is a survey study being conducted to describe how subjects with Hidradenitis suppurativa (HS) respond to treatment with gentian violet. The study will rely primarily on qualitative survey responses and quantitative changes in skin appearance.

Key facts

Study ID

NCT04388163

Run by

Wake Forest University Health Sciences

People needed

0

Starts

2025-08-01

Expected to finish

2026-12-01

Last updated by the study team

2025-09-04

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have active HS, be willing to undergo one application of HS, and agree to follow-up in one month.

You may not qualify if…

• Exclusion criteria include children, absent HS lesions at the time of clinic, and cognitive/physical impairments that would make them unable to assess quality of life factors of the survey.

Where it is running

• Wake Forest School of Medicine — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.